Mark leads ZS’s Cambridge office in the U.K., where he supports both established and emerging pharma companies to improve patient care. Mark has worked at ZS for over 15 years and has been based in the firm’s U.S. and European offices, working to address challenges in markets around the world. 

Mark has over 15 years of consulting experience in the pharmaceutical and biotech sector, during which time he has developed expertise in pipeline and launch strategy topics, including evidence planning, market access and pricing, forecasting, brand planning and life cycle management.

Mark has a bachelor’s in mathematics from Cambridge University.